输血相关急性肺损伤诊断国际专家共识再认识*

doi:10.3969/j.issn.1671-2587.2022.04.023

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (4): 528-532.DOI: 10.3969/j.issn.1671-2587.2022.04.023

输血相关急性肺损伤诊断国际专家共识再认识^*

高宗帅, 李志强

200233 上海交通大学附属第六人民医院

收稿日期:2022-05-10 出版日期:2022-08-20 发布日期:2022-08-19
通讯作者: 李志强,男,主要从事血液病诊治和临床输血基础与应用研究,（E-mail）kcb039@126.com。
作者简介:高宗帅（1989-）, 男,山东人,研究生在读,技师,主要从事血型血清学与分子生物学技术研究,（E-mail）89580300@qq.com。
基金资助:
*本课题受上海市2020年度“科技创新行动计划”生物医药科技支撑专项项目（No.0S31902900）资助

Received:2022-05-10 Online:2022-08-20 Published:2022-08-19

摘要/Abstract

摘要： 输血相关急性肺损伤（transfusion-related acute lung injury,TRALI）是一种严重的输血反应,也是导致输血相关死亡的主要因素之一,死亡率6％~12％。到目前为止,TRALI无特异性诊断标志物,容易导致误诊或漏诊。本文通过阐述TRALI诊断相关国际专家共识,涉及到加拿大共识、柏林共识以及2019年新的国际共识,涵盖了TRALI的标准化定义、危险因素和鉴别诊断等内容,为提高TRALI的诊断水平提供依据。

中图分类号:

R457

高宗帅, 李志强. 输血相关急性肺损伤诊断国际专家共识再认识^*[J]. 临床输血与检验, 2022, 24(4): 528-532.

参考文献

[1] KULDANEK S A,KELHER M,SILLIMAN C C.Risk factors,management and prevention of transfusion-related acute lung injury:a comprehensive update[J]. Expert Rev Hematol,2019,12(9):773-785.
[2] BAYAT B,SACHS U J.Transfusion-related acute lung injury:an overview[J].Curr Pharm Des,2012,18(22):3236-3240.
[3] ROUBINIAN N.TACO and TRALI:biology,risk factors,and prevention strategies[J]. Hematology Am Soc Hematol Educ Program,2018,2018(1):585-594.
[4] PETERS A L,VAN DE WEERDT E K,GOUDSWAARD E J,et al.Reporting transfusion-related acute lung injury by clinical and preclinical disciplines[J]. Blood Transfus,2018,16(3):227-234.
[5] BARNARD R D.Indiscriminate transfusion:a critique of case reports illustrating hypersensitivity reactions[J]. N Y State J Med,1951,51(20):2399-2402.
[6] BRITTINGHAM T E.Immunologic studies on leukocytes[J]. Vox Sang,1957,2(4):242-248.
[7] PHILIPPS E,FLEISCHNER F G.Pulmonary edema in the course of a blood transfusion without overloading the circulation[J]. Dis Chest,1966,50(6):619-623.
[8] WARD H N.Pulmonary infiltrates associated with leukoagglutinin transfusion reactions[J].Ann Intern Med,1970,73(5):689-694.
[9] THOMPSON J S,SEVERSON C D,PARMELY M J,et al.Pulmonary“hypersensitivity”reactions induced by transfusion of non-HL-A leukoagglutinins[J].N Engl J Med,1971,284(20):1120-1125.
[10] POPOVSKY M A,ABEL M D,MOORE S B.Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies[J].Am Rev Respir Dis,1983,128(1):185-189.
[11] POPOVSKY M A,MOORE S B.Diagnostic and pathogenetic considerations in transfusion-related acute lung injury[J]. Transfusion,1985,25(6):573-577.
[12] SILLIMAN C C,BOSHKOV L K,MEHDIZADEHKAS HI Z,et al.Transfusion-related acute lung injury:epidemiology and a prospective analysis of etiologic factors[J]. Blood,2003,101(2):454-462.
[13] KLEINMAN S,CAULFIELD T,CHAN P,et al.Toward an understanding of transfusion-related acute lung injury:statement of a consensus panel[J]. Transfusion,2004,44(12):1774-1789.
[14] TOY P,POPOVSKY M A,ABRAHAM E,et al.Transfusion-related acute lung injury:definition and review[J]. Crit Care Med,2005,33(4):721-726.
[15] FERGUSON N D,FAN E,CAMPOROTA L,et al.The Berlin definition of ARDS:an expanded rationale,justification,and supplementary material[J]. Intensive Care Med,2012,38(10):1573-1582.
[16] VLAAR A P J,TOY P,FUNG M,et al. A consensus redefinition of transfusion-related acute lung injury[J]. Transfusion,2019,59(7):2465-2476.
[17] TOY P,GAJIC O,BACCHETTI P,et al.Transfusion-related acute lung injury:incidence and risk factors[J]. Blood,2012,119(7):1757-1767.
[18] VLAAR A P J,HOFSTRA J J,DETERMANN R M,et al. The incidence,risk factors,and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients:a prospective nested case-control study[J]. Blood,2011,117(16):4218-4225.
[19] VLAAR A P J,BINNEKADE J M,PRINS D,et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill:a nested case-control study[J]. Crit Care Med,2010,38(3):771-778.
[20] GAJIC O,RANA R,WINTERS J L,et al.Transfusion-related acute lung injury in the critically ill:prospective nested case-control study[J]. Am J Respir Crit Care Med,2007,176(9):886-891.
[21] BENSON A B,AUSTIN G L,BERG M,et al.Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding[J]. Intensive Care Med,2010,36(10):1710-1717.
[22] ANDREU G,BOUDJEDIR K,MULLER J Y,et al.Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the French hemovigilance network from 2007 to 2013[J]. Transfus Med Rev,2018,32(1):16-27.
[23] BENSON A B,BURTON J R Jr,AUSTIN G L,et al. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation[J]. Liver Transpl,2011,17(2):149-158.
[24] NAKAZAWA H,OHNISHI H,OKAZAKI H,et al.Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients:a prospective case-controlled study[J]. Transfusion,2009,49(11):2434-2441.
[25] 中华人民共和国国家卫生健康委员会.中华人民共和国卫生行业标准 WS/T 624-2018:输血反应分类[S/OL].(2020-11-10).http://www.nhc.gov.cn/ewebeditor/uploadfile/2019/01/20190110141959832.pdf.

输血相关急性肺损伤诊断国际专家共识再认识^*

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	潘雪, 宋英伟, 林洁, 张晓娟, 张婷, 刘丽, 汪德清, 于洋. 骨科手术患者术前贫血对围手术期输血与临床结局的影响[J]. 临床输血与检验, 2022, 24(4): 409-415.
[2]	周琳, 慈璇, 邵小宝, 王华, 杨圆, 高凤威, 朱培元. 结直肠恶性肿瘤患者围手术期输血和术后感染并发症的相关性研究^*[J]. 临床输血与检验, 2022, 24(4): 416-421.
[3]	范可欣, 朱鹏汇, 王云, 王勇军, 张宁洁. 基于机器学习算法建立胎母输血综合征预测模型^*[J]. 临床输血与检验, 2022, 24(4): 427-432.
[4]	王帅, 李君. 肝硬化患者ABO和Rh（D）同型随机配合性输血Rh（CcEe）同种免疫及影响因素分析[J]. 临床输血与检验, 2022, 24(4): 443-447.
[5]	李艳辉, 施琳颖, 周谋, 许京菁, 谢婷婷, 单桂秋. 加温加压输血仪器核心性能检测的实验研究^*[J]. 临床输血与检验, 2022, 24(4): 448-454.
[6]	吴军营, 王凌霞, 吴茜茜, 朱志宸, 王波, 杨欢. NFKBIZ基因在乳腺癌中的生物学功能及临床诊断价值研究^*[J]. 临床输血与检验, 2022, 24(4): 482-487.
[7]	刘静, 李龙, 马喜迎. γ-干扰素释放试验联合FadD9重组蛋白对重症肺结核患者的诊断及死亡预后的预测价值[J]. 临床输血与检验, 2022, 24(4): 488-496.
[8]	刘峰, 周吉成, 刘榕孜, 谭彬宾, 谢春梅. 国内部分高等医药院校开设输血医学课程的现状分析及建议[J]. 临床输血与检验, 2022, 24(4): 501-506.
[9]	康澜, 李世林, 杨春晖. 血液成分中病原体灭活技术及其研究进展[J]. 临床输血与检验, 2022, 24(4): 521-527.
[10]	李玉璇, 张玉龙, 马兴焕, 强书毓, 王小慧, 詹林盛. 基于过冷液体凝固放热的无源输血加温器对血液质量的影响评估[J]. 临床输血与检验, 2022, 24(3): 302-307.
[11]	李津杞, 臧艳, 李津婴, 查占山, 钱宝华. 输血治疗儿童遗传性难治性溶血性贫血的回顾性分析[J]. 临床输血与检验, 2022, 24(3): 325-327.
[12]	张慧, 容可, 王思贤, 闻才李, 程晓文. 骨科择期手术备血策略的建立及术中用血分析[J]. 临床输血与检验, 2022, 24(3): 333-337.
[13]	康晓珍, 彭炜童, 魏寿忠. 直接抗人球蛋白试验阳性分型与输血疗效关系探讨^*[J]. 临床输血与检验, 2022, 24(3): 338-342.
[14]	王欢, 徐方, 郭建荣. 基于代谢组学的红细胞贮存损伤相关研究新进展^*[J]. 临床输血与检验, 2022, 24(3): 403-408.
[15]	张若洋, 杨东, 冯晨晨, 史丽莉, 李慧, 薛敏, 丁文艺, 陈青. 基因分型技术在ABO放散型亚型鉴定中的应用^*[J]. 临床输血与检验, 2022, 24(2): 142-146.